BACKGROUND: Although it is known that most patients do not consistently take controller medications every day, the impact of nonadherence on asthma control is not well documented. OBJECTIVE: To establish the relationship between medication adherence and symptom control in adolescents and young adults with asthma. METHODS: A total of 756 adolescents and young adults diagnosed as having mild to moderate asthma on entry into the original study underwent 6 monthly telephone interviews as an ancillary project to the Childhood Asthma Management Program Continuation Study. Participants were queried about medication use and symptom control within each 1-month interview window. Strategies adopted to improve self-report accuracy included use of repeated interviews, confidential reporting to staff unknown to the participants, and use of questions focused on recent behavior. RESULTS: Only participants who were consistently on inhaled corticosteroids (ICSs) for the entire 6-month study interval were included. Three groups of patients were contrasted: those not on ICSs (n = 420), those on ICSs with high adherence (> or = 75% of medication taken, n = 90), and those on ICSs with low/medium adherence (< 75% of medication taken, n = 148). Participants in the low/medium adherence group reported, on average, less symptom control and more variability in wheezing, awakening at night, missed activities, and beta2-agonist use during the 6-month period, although most in this group perceived their asthma to be under good control. CONCLUSION: Despite extensive patient education and support, diminished ICS adherence was frequent and undermined symptom control in this group of adolescents and young adults with mild to moderate asthma.
BACKGROUND: Although it is known that most patients do not consistently take controller medications every day, the impact of nonadherence on asthma control is not well documented. OBJECTIVE: To establish the relationship between medication adherence and symptom control in adolescents and young adults with asthma. METHODS: A total of 756 adolescents and young adults diagnosed as having mild to moderate asthma on entry into the original study underwent 6 monthly telephone interviews as an ancillary project to the Childhood Asthma Management Program Continuation Study. Participants were queried about medication use and symptom control within each 1-month interview window. Strategies adopted to improve self-report accuracy included use of repeated interviews, confidential reporting to staff unknown to the participants, and use of questions focused on recent behavior. RESULTS: Only participants who were consistently on inhaled corticosteroids (ICSs) for the entire 6-month study interval were included. Three groups of patients were contrasted: those not on ICSs (n = 420), those on ICSs with high adherence (> or = 75% of medication taken, n = 90), and those on ICSs with low/medium adherence (< 75% of medication taken, n = 148). Participants in the low/medium adherence group reported, on average, less symptom control and more variability in wheezing, awakening at night, missed activities, and beta2-agonist use during the 6-month period, although most in this group perceived their asthma to be under good control. CONCLUSION: Despite extensive patient education and support, diminished ICS adherence was frequent and undermined symptom control in this group of adolescents and young adults with mild to moderate asthma.
Authors: Suzanne Domel Baxter; Albert F Smith; Mark S Litaker; Caroline H Guinn; Nicole M Shaffer; Michelle L Baglio; Francesca H A Frye Journal: Ann Epidemiol Date: 2004-07 Impact factor: 3.797
Authors: G B Diette; A W Wu; E A Skinner; L Markson; R D Clark; R C McDonald; J P Healy; M Huber; D M Steinwachs Journal: Arch Intern Med Date: 1999 Dec 13-27
Authors: Marion F Zabinski; Tracy Daly; Gregory J Norman; Joan W Rupp; Karen J Calfas; James F Sallis; Kevin Patrick Journal: J Am Diet Assoc Date: 2006-06
Authors: Faustinus Onyirimba; Andrea Apter; Susan Reisine; Mark Litt; Corliss McCusker; MaryLou Connors; Richard ZuWallack Journal: Ann Allergy Asthma Immunol Date: 2003-04 Impact factor: 6.347
Authors: Doryliz Vila; Cynthia S Rand; Michael D Cabana; Amarilis Quiñones; Mirla Otero; Christina Gamache; Rafael Ramírez; Pedro García; Glorisa Canino Journal: J Asthma Date: 2010-11-01 Impact factor: 2.515
Authors: Gregory S Sawicki; Robert C Strunk; Brooke Schuemann; Robert Annett; Scott Weiss; Anne L Fuhlbrigge Journal: Ann Allergy Asthma Immunol Date: 2010-01 Impact factor: 6.347
Authors: Henry N Young; S Nadra Havican; Sara Griesbach; Joshua M Thorpe; Betty A Chewning; Christine A Sorkness Journal: Telemed J E Health Date: 2012-06-01 Impact factor: 3.536